Series F, closed in December 2025, builds on recent financing activity to support launch readiness leading up to the Orca-T ® PDUFA date of April 6, 2026 Funding also enables pipeline advancements ...
Dr. Gwen Nichols explains how Orca‑T may reduce graft-versus-host disease and impact treatment decisions for certain patients with blood cancers. As treatment options for acute myeloid leukemia (AML) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results